CD3-specific antibody-induced active tolerance: from bench to bedside
Author:
Publisher
Springer Science and Business Media LLC
Subject
Energy Engineering and Power Technology,Fuel Technology
Link
http://www.nature.com/articles/nri1000.pdf
Reference117 articles.
1. Kung, P., Goldstein, G., Reinherz, E. L. & Schlossman, S. F. Monoclonal antibodies defining distinctive human T-cell surface antigens. Science 206, 347–349 (1979).
2. Cosimi, A. B. et al. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N. Engl. J. Med. 305, 308–314 (1981). The first pilot clinical trial to indicate that OKT3 can reverse ongoing renal-allograft rejection.
3. Cosimi, A. B. et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation 32, 535–539 (1981).
4. Clevers, H., Alarcon, B., Wileman, T. & Terhorst, C. The T-cell receptor/CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol. 6, 629–662 (1988).
5. Davis, M. M. & Chien, Y. H. in Fundamental Immunology (ed. Paul, W. E.) 341–366 (Raven Press, New York, 1999).
Cited by 260 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives;Current Atherosclerosis Reports;2024-07-15
2. IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation;Proceedings of the National Academy of Sciences;2024-03-21
3. Cationic nanoparticles-based approaches for immune tolerance induction in vivo;Journal of Controlled Release;2024-02
4. Revolutionizing cancer immunotherapy: unleashing the potential of bispecific antibodies for targeted treatment;Frontiers in Immunology;2023-12-01
5. Engineering therapeutic monoclonal antibodies;Journal of Allergy and Clinical Immunology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3